Idecabtagene Vicleucel (Ide-cel) Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Who Have Received a Prior BCMA-Targeted Therapy: Real World, Multi-Institutional Experience

Authors :: Christopher J. Ferreri
Michelle A.T. Hildebrandt
Hamza Hashmi
Leyla O. Shune
Joseph P. McGuirk
Douglas W. Sborov
Charlotte B Wagner
M. Hakan Kocoglu
Shebli Atrash
Peter M. Voorhees
Jack Khouri
Danai Dima
Aimaz Afrough
Aishwarya Sannareddy
Gary Simmons
James Davis
Nilesh Kalariya
Lauren C. Peres
Melissa Alsina
Frederick L. Locke
Surbhi Sidana
Doris K. Hansen
Krina Patel
Omar Alexis Castaneda Puglianini
Source :: Blood. 140:1856-1858
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Tools